FDA issues Class II recall of over 13,000 bottles of chlorthalidone
सिर्फ तथ्य

FDA issues Class II recall of over 13,000 bottles of chlorthalidone

सारांश

The U.S. Food and Drug Administration has recalled more than 13,000 bottles of the blood-pressure drug chlorthalidone after dissolution tests failed, urging patients to consult their providers.

The U.S. Food and Drug Administration announced a nationwide recall of 13,567 bottles of chlorthalidone 25 mg tablets after the product failed to meet dissolution specifications, which could reduce its effectiveness. The recall, classified as a Class II event on Sept. 17, indicates a low likelihood of serious health consequences but acknowledges the possibility of temporary or reversible effects.

The affected medication, manufactured by Inventia Healthcare Limited, is sold in bottles of 100 tablets and carries the NDC 64980-599-01, batch code RISA24002, with an expiration date of April 2027. This action follows a similar recall of more than 11,000 bottles of the same drug in June.

Patients who may have the recalled product are advised to contact their doctor or pharmacist for guidance. > "While recall notifications can be frightening, it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine," said Jennifer Young, PharmD, lead medication safety specialist at the Institute for Safe Medication Practices.

Health professionals recommend not stopping the medication abruptly, as doing so could pose greater risks than the potential issues identified in the recall.

स्रोत

AOL.com

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।